Cargando…
Infliximab Induces Increase in Triglyceride Levels in Psoriatic Arthritis Patients
Objectives. To evaluate lipid profile changes after anti-TNF therapy in patients with psoriatic arthritis (PsA). Methods. Fifteen PsA patients (eight polyarticular, four oligoarticular, two axial, and one mutilating) under infliximab were included. None had dyslipoproteinemia or previous statin use....
Autores principales: | Castro, Karla R., Aikawa, Nádia E., Saad, Carla Gonçalves, Moraes, Júlio C. B., Medeiros, Ana C., Mota, Licia Maria H., Silva, Clovis A. A., Bonfá, Eloísa, Carvalho, Jozélio F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143445/ https://www.ncbi.nlm.nih.gov/pubmed/21804855 http://dx.doi.org/10.1155/2011/352686 |
Ejemplares similares
-
Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis
por: G.S. Saad, Carla, et al.
Publicado: (2023) -
Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up
por: Usuba, Fany Solange, et al.
Publicado: (2020) -
Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?
por: Aikawa, Nadia Emi, et al.
Publicado: (2011) -
Infliximab (Remicade) in the treatment of psoriatic arthritis
por: Mease, Philip
Publicado: (2006) -
A sarcoidosis patient developing psoriatic arthritis 18 years later: First description
por: de Carvalho, Jozélio Freire
Publicado: (2023)